{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T04:04:08Z","timestamp":1749787448192,"version":"3.41.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["767572","767572","767572","767572","767572","767572","767572","767572","767572"],"award-info":[{"award-number":["767572","767572","767572","767572","767572","767572","767572","767572","767572"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Estonian Research Council, Estonia","award":["PSG819","PSG819","PSG819","PRG2643","PRG2643","PSG819","PSG819","PRG2643"],"award-info":[{"award-number":["PSG819","PSG819","PSG819","PRG2643","PRG2643","PSG819","PSG819","PRG2643"]}]},{"DOI":"10.13039\/501100003510","name":"Estonian Ministry of Education and Research","doi-asserted-by":"crossref","award":["TK218","TK218","TK218","TK218","TK218","TK218","TK218","TK218","TK218"],"award-info":[{"award-number":["TK218","TK218","TK218","TK218","TK218","TK218","TK218","TK218","TK218"]}],"id":[{"id":"10.13039\/501100003510","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>C-mannosyl tryptophan (CMW), also known as C-glycosyltryptophan, is a novel biomarker that is strongly correlated to chronic kidney disease (CKD) incidence and progression risk and mortality among earlier stages of CKD patients prior to end stage kidney disease. This study determined concentrations of CMW in blood and spent dialysate of CKD patients on chronic hemodialysis (HD) for the first time, and investigated the possibility for optical estimation of CMW concentrations in spent dialysate, its intradialytic removal and time-averaged concentration (TAC) of CMW based on optical measurements of spent dialysate. In total, 264 pre- and postdialysis blood samples, and 528 spent dialysate samples from 88 HD sessions of 22 patients were analyzed using high pressure liquid chromatography and spectrophotometry. We identified that CMW concentrations in CKD patients on chronic HD are over 10 times higher compared to earlier reported CMW concentrations in healthy subjects. The concentration of CMW in spent dialysate can be monitored based on spectrophotometric analysis of spent dialysate (r\u2009&gt;\u20090.939, standard error: 0.07\u00a0\u03bcmol\/L) and it is possible to evaluate CMW-based HD adequacy parameters, such as reduction ratio, mass of total removed solute, and TAC without blood sampling. In future, optical monitoring of CMW could be potentially used to improve clinical management of hemodialysis patients.<\/jats:p>","DOI":"10.1038\/s41598-025-01844-z","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T08:24:19Z","timestamp":1749716659000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intradialytic optical assessment of C-mannosyl tryptophan removal using spent dialysate"],"prefix":"10.1038","volume":"15","author":[{"given":"Joosep","family":"Paats","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annika","family":"Adoberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liisi","family":"Leis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Arund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Lauri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merike","family":"Luman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risto","family":"Tanner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Holmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristjan","family":"Pilt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivo","family":"Fridolin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"key":"1844_CR1","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1093\/ndt\/gfz174","volume":"34","author":"KJ Jager","year":"2019","unstructured":"Jager, K. J. et al. A single number for advocacy and communication\u2014Worldwide more than 850 million individuals have kidney diseases. Nephrol. Dial. Transplant. 34, 1803\u20131805. https:\/\/doi.org\/10.1093\/ndt\/gfz174 (2019).","journal-title":"Nephrol. Dial. Transplant."},{"key":"1844_CR2","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1681\/ASN.2013121264","volume":"25","author":"TW Meyer","year":"2014","unstructured":"Meyer, T. W. & Hostetter, T. H. Approaches to uremia. J. Am. Soc. Nephrol. 25, 2151\u20132158. https:\/\/doi.org\/10.1681\/ASN.2013121264 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1844_CR3","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41581-022-00542-7","volume":"18","author":"AK Bello","year":"2022","unstructured":"Bello, A. K. et al. Epidemiology of haemodialysis outcomes. Nat. Rev. Nephrol. 18, 378\u2013395. https:\/\/doi.org\/10.1038\/s41581-022-00542-7 (2022).","journal-title":"Nat. Rev. Nephrol."},{"key":"1844_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3390\/toxins10010033","volume":"10","author":"R Vanholder","year":"2018","unstructured":"Vanholder, R., Pletinck, A., Schepers, E. & Glorieux, G. Biochemical and clinical impact of organic uremic retention solutes: A comprehensive update. Toxins 10, 33. https:\/\/doi.org\/10.3390\/toxins10010033 (2018).","journal-title":"Toxins"},{"key":"1844_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135657","volume":"10","author":"H Tanaka","year":"2015","unstructured":"Tanaka, H., Sirich, T. L., Plummer, N. S., Weaver, D. S. & Meyer, T. W. An enlarged profile of uremic solutes. PLoS ONE 10, e0135657. https:\/\/doi.org\/10.1371\/journal.pone.0135657 (2015).","journal-title":"PLoS ONE"},{"key":"1844_CR6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev-physiol-020518-114605","volume":"81","author":"WR Zhang","year":"2019","unstructured":"Zhang, W. R. & Parikh, C. R. Biomarkers of acute and chronic kidney disease. Annu. Rev. Physiol. 81, 309\u2013333. https:\/\/doi.org\/10.1146\/annurev-physiol-020518-114605 (2019).","journal-title":"Annu. Rev. Physiol."},{"key":"1844_CR7","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1440-1797.2010.01361.x","volume":"15","author":"GH Tesch","year":"2010","unstructured":"Tesch, G. H. Review: Serum and urine biomarkers of kidney disease\u2014A pathophysiological perspective. Nephrology 15, 609\u2013616. https:\/\/doi.org\/10.1111\/j.1440-1797.2010.01361.x (2010).","journal-title":"Nephrology"},{"key":"1844_CR8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.abb.2015.07.018","volume":"589","author":"M Breit","year":"2016","unstructured":"Breit, M. & Weinberger, K. M. Metabolic biomarkers for chronic kidney disease. Arch. Biochem. Biophys. 589, 62\u201380. https:\/\/doi.org\/10.1016\/j.abb.2015.07.018 (2016).","journal-title":"Arch. Biochem. Biophys."},{"key":"1844_CR9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrneph.2017.30","volume":"13","author":"B Hocher","year":"2017","unstructured":"Hocher, B. & Adamski, J. Metabolomics for clinical use and research in chronic kidney disease. Nat. Rev. Nephrol. 13, 269\u2013284. https:\/\/doi.org\/10.1038\/nrneph.2017.30 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"1844_CR10","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1056\/NEJMra054415","volume":"354","author":"LA Stevens","year":"2006","unstructured":"Stevens, L. A., Coresh, J., Greene, T. & Levey, A. S. Assessing kidney function\u2014Measured and estimated glomerular filtration rate. N. Engl. J. Med. 354, 2473\u20132483. https:\/\/doi.org\/10.1056\/NEJMra054415 (2006).","journal-title":"N. Engl. J. Med."},{"key":"1844_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3390\/toxins10040155","volume":"10","author":"L Koppe","year":"2018","unstructured":"Koppe, L., Fouque, D. & Soulage, C. O. The role of gut microbiota and diet on uremic retention solutes production in the context of chronic kidney disease. Toxins 10, 155. https:\/\/doi.org\/10.3390\/toxins10040155 (2018).","journal-title":"Toxins"},{"key":"1844_CR12","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1681\/ASN.2014111099","volume":"27","author":"P Sekula","year":"2016","unstructured":"Sekula, P. et al. A metabolome-wide association study of kidney function and disease in the general population. J. Am. Soc. Nephrol. 27, 1175\u20131188. https:\/\/doi.org\/10.1681\/ASN.2014111099 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1844_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfad286","author":"AC van der Burgh","year":"2024","unstructured":"van der Burgh, A. C. et al. Circulating metabolites associated with kidney function decline and incident CKD: A multi-platform population-based study. Clin. Kidney J. https:\/\/doi.org\/10.1093\/ckj\/sfad286 (2024).","journal-title":"Clin. Kidney J."},{"key":"1844_CR14","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1053\/j.ajkd.2021.01.018","volume":"78","author":"I Steinbrenner","year":"2021","unstructured":"Steinbrenner, I. et al. Urine metabolite levels, adverse kidney outcomes, and mortality in CKD patients: A metabolome-wide association study. Am. J. Kidney Dis. 78, 669\u2013677. https:\/\/doi.org\/10.1053\/j.ajkd.2021.01.018 (2021).","journal-title":"Am. J. Kidney Dis."},{"key":"1844_CR15","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.2215\/CJN.00220121","volume":"16","author":"MR Denburg","year":"2021","unstructured":"Denburg, M. R. et al. Metabolite biomarkers of ckd progression in children. Clin. J. Am. Soc. Nephrol. 16, 1178\u20131189. https:\/\/doi.org\/10.2215\/CJN.00220121 (2021).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1844_CR16","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s10719-020-09938-8","volume":"37","author":"S Minakata","year":"2020","unstructured":"Minakata, S. et al. Monomeric c-mannosyl tryptophan is a degradation product of autophagy in cultured cells. Glycoconj. J. 37, 635\u2013645. https:\/\/doi.org\/10.1007\/s10719-020-09938-8 (2020).","journal-title":"Glycoconj. J."},{"key":"1844_CR17","doi-asserted-by":"publisher","first-page":"781","DOI":"10.18388\/abp.2000_3996","volume":"47","author":"A Furmanek","year":"2000","unstructured":"Furmanek, A. & Hofsteenge, J. Protein c-mannosylation: Facts and questions. Acta Biochim. Pol. 47, 781\u2013789 (2000).","journal-title":"Acta Biochim. Pol."},{"key":"1844_CR18","doi-asserted-by":"publisher","first-page":"5258","DOI":"10.3390\/molecules26175258","volume":"26","author":"S Minakata","year":"2021","unstructured":"Minakata, S. et al. Protein c-mannosylation and c-mannosyl tryptophan in chemical biology and medicine. Molecules 26, 5258. https:\/\/doi.org\/10.3390\/molecules26175258 (2021).","journal-title":"Molecules"},{"key":"1844_CR19","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41580-020-00294-x","volume":"21","author":"KT Schjoldager","year":"2020","unstructured":"Schjoldager, K. T., Narimatsu, Y., Joshi, H. J. & Clausen, H. Global view of human protein glycosylation pathways and functions. Nat. Rev. Mol. Cell Biol. 21, 729\u2013749. https:\/\/doi.org\/10.1038\/s41580-020-00294-x (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1844_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202200822","author":"R Qi","year":"2022","unstructured":"Qi, R. et al. Visible-light-promoted stereoselective c(sp 3)\u2212h glycosylation for the synthesis of c-glycoamino acids and c-glycopeptides. Angew. Chemie Int. Ed. https:\/\/doi.org\/10.1002\/anie.202200822 (2022).","journal-title":"Angew. Chemie Int. Ed."},{"key":"1844_CR21","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1093\/glycob\/cwm050","volume":"17","author":"K Julenius","year":"2007","unstructured":"Julenius, K. NetCGlyc 1.0: prediction of mammalian c-mannosylation sites. Glycobiology 17, 868\u2013876. https:\/\/doi.org\/10.1093\/glycob\/cwm050 (2007).","journal-title":"Glycobiology"},{"key":"1844_CR22","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41589-022-01219-9","volume":"19","author":"JS Bloch","year":"2023","unstructured":"Bloch, J. S. et al. Structure, sequon recognition and mechanism of tryptophan c-mannosyltransferase. Nat. Chem. Biol. 19, 575\u2013584. https:\/\/doi.org\/10.1038\/s41589-022-01219-9 (2023).","journal-title":"Nat. Chem. Biol."},{"key":"1844_CR23","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/oxfordjournals.jbchem.a124343","volume":"115","author":"K Horiuchi","year":"1994","unstructured":"Horiuchi, K. et al. A hydrophilic tetrahydro-\u03b2-carboline in human urine. J. Biochem. 115, 362\u2013366. https:\/\/doi.org\/10.1093\/oxfordjournals.jbchem.a124343 (1994).","journal-title":"J. Biochem."},{"issue":"Pt 1","key":"1844_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1042\/bj3430011","volume":"343","author":"B Gutsche","year":"1999","unstructured":"Gutsche, B., Grun, C., Scheutzow, D. & Herderich, M. Tryptophan glycoconjugates in food and human urine. Biochem. J. 343(Pt 1), 11\u201319 (1999).","journal-title":"Biochem. J."},{"key":"1844_CR25","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/S0002-9343(00)00693-8","volume":"110","author":"R Takahira","year":"2001","unstructured":"Takahira, R. et al. Tryptophan glycoconjugate as a novel marker of renal function. Am. J. Med. 110, 192\u2013197. https:\/\/doi.org\/10.1016\/S0002-9343(00)00693-8 (2001).","journal-title":"Am. J. Med."},{"key":"1844_CR26","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1111\/j.1523-1755.2004.00521.x","volume":"65","author":"K Yonemura","year":"2004","unstructured":"Yonemura, K., Takahira, R., Yonekawa, O., Wada, N. & Hishida, A. The diagnostic value of serum concentrations of 2-(\u03b1-mannopyranosyl)-l-tryptophan for normal renal function. Kidney Int. 65, 1395\u20131399. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00521.x (2004).","journal-title":"Kidney Int."},{"key":"1844_CR27","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/ki.2013.497","volume":"85","author":"MA Niewczas","year":"2014","unstructured":"Niewczas, M. A. et al. Uremic solutes and risk of end-stage renal disease in type 2 diabetes: Metabolomic study. Kidney Int. 85, 1214\u20131224. https:\/\/doi.org\/10.1038\/ki.2013.497 (2014).","journal-title":"Kidney Int."},{"key":"1844_CR28","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.3390\/ijms21041522","volume":"21","author":"J Paats","year":"2020","unstructured":"Paats, J. et al. Serum levels and removal by haemodialysis and haemodiafiltration of tryptophan-derived uremic toxins in eskd patients. Int. J. Mol. Sci. 21, 1522. https:\/\/doi.org\/10.3390\/ijms21041522 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1844_CR29","doi-asserted-by":"publisher","first-page":"e0156541","DOI":"10.1371\/journal.pone.0156541","volume":"11","author":"J Arund","year":"2016","unstructured":"Arund, J., Luman, M., Uhlin, F., Tanner, R. & Fridolin, I. Is fluorescence valid to monitor removal of protein bound uremic solutes in dialysis?. PLoS ONE 11, e0156541. https:\/\/doi.org\/10.1371\/journal.pone.0156541 (2016).","journal-title":"PLoS ONE"},{"key":"1844_CR30","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s11306-019-1543-0","volume":"15","author":"M Yamamoto","year":"2019","unstructured":"Yamamoto, M., Pinto-Sanchez, M. I., Bercik, P. & Britz-McKibbin, P. Metabolomics reveals elevated urinary excretion of collagen degradation and epithelial cell turnover products in irritable bowel syndrome patients. Metabolomics 15, 82. https:\/\/doi.org\/10.1007\/s11306-019-1543-0 (2019).","journal-title":"Metabolomics"},{"key":"1844_CR31","doi-asserted-by":"publisher","first-page":"e103878","DOI":"10.1371\/journal.pone.0103878","volume":"9","author":"AV Fonin","year":"2014","unstructured":"Fonin, A. V., Sulatskaya, A. I., Kuznetsova, I. M. & Turoverov, K. K. Fluorescence of dyes in solutions with high absorbance inner filter effect correction. PLoS ONE 9, e103878. https:\/\/doi.org\/10.1371\/journal.pone.0103878 (2014).","journal-title":"PLoS ONE"},{"key":"1844_CR32","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1080\/05704928.2017.1345758","volume":"52","author":"T Wang","year":"2017","unstructured":"Wang, T., Zeng, L.-H. & Li, D.-L. A review on the methods for correcting the fluorescence inner-filter effect of fluorescence spectrum. Appl. Spectrosc. Rev. 52, 883\u2013908. https:\/\/doi.org\/10.1080\/05704928.2017.1345758 (2017).","journal-title":"Appl. Spectrosc. Rev."},{"key":"1844_CR33","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1093\/ndt\/gfl147","volume":"21","author":"F Uhlin","year":"2006","unstructured":"Uhlin, F., Fridolin, I., Magnusson, M. & Lindberg, L.-G. Dialysis dose (kt\/v) and clearance variation sensitivity using measurement of ultraviolet-absorbance (on-line), blood urea, dialysate urea and ionic dialysance. Nephrol. Dial. Transplant. 21, 2225\u20132231. https:\/\/doi.org\/10.1093\/ndt\/gfl147 (2006).","journal-title":"Nephrol. Dial. Transplant."},{"key":"1844_CR34","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","volume":"327","author":"JM Bland","year":"1986","unstructured":"Bland, J. M. & Altman, D. G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 327, 307\u2013310. https:\/\/doi.org\/10.1016\/S0140-6736(86)90837-8 (1986).","journal-title":"Lancet"},{"key":"1844_CR35","unstructured":"Esbensen, K. Multivariate data analysis\u2014in practice. Introduction to multivariate data analysis and experimental design. (CAMO Software, Oslo, 2009)."},{"key":"1844_CR36","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1111\/j.1523-1755.2005.00238.x","volume":"67","author":"S Eloot","year":"2005","unstructured":"Eloot, S. et al. Kinetic behavior of urea is different from that of other water-soluble compounds: The case of the guanidino compounds. Kidney Int. 67, 1566\u20131575. https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00238.x (2005).","journal-title":"Kidney Int."},{"key":"1844_CR37","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1177\/039139880202500802","volume":"25","author":"I Fridolin","year":"2002","unstructured":"Fridolin, I., Magnusson, M. & Lindberg, L.-G. On-line monitoring of solutes in dialysate using absorption of ultraviolet radiation: Technique description. Int. J. Artif. Organs 25, 748\u2013761. https:\/\/doi.org\/10.1177\/039139880202500802 (2002).","journal-title":"Int. J. Artif. Organs"},{"key":"1844_CR38","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S1073-4449(12)80029-X","volume":"2","author":"LJ Garred","year":"1995","unstructured":"Garred, L. J. Dialysate-based kinetic modeling. Adv. Ren. Replace. Ther. 2, 305\u2013318. https:\/\/doi.org\/10.1016\/S1073-4449(12)80029-X (1995).","journal-title":"Adv. Ren. Replace. Ther."},{"key":"1844_CR39","doi-asserted-by":"publisher","first-page":"E55","DOI":"10.1111\/aor.13011","volume":"42","author":"P-S Lim","year":"2018","unstructured":"Lim, P.-S. et al. Precise quantitative assessment of the clinical performances of two high-flux polysulfone hemodialyzers in hemodialysis: Validation of a blood-based simple kinetic model versus direct dialysis quantification. Artif. Organs 42, E55\u2013E66. https:\/\/doi.org\/10.1111\/aor.13011 (2018).","journal-title":"Artif. Organs"},{"key":"1844_CR40","doi-asserted-by":"publisher","first-page":"17400","DOI":"10.1038\/s41598-017-17107-5","volume":"7","author":"P Sekula","year":"2017","unstructured":"Sekula, P. et al. From discovery to translation: characterization of c-mannosyltryptophan and pseudouridine as markers of kidney function. Sci. Rep. 7, 17400. https:\/\/doi.org\/10.1038\/s41598-017-17107-5 (2017).","journal-title":"Sci. Rep."},{"key":"1844_CR41","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1053\/j.ajkd.2015.08.029","volume":"67","author":"RC Vanholder","year":"2016","unstructured":"Vanholder, R. C., Eloot, S. & Glorieux, G. L. R. L. Future avenues to decrease uremic toxin concentration. Am. J. Kidney Dis. 67, 664\u2013676. https:\/\/doi.org\/10.1053\/j.ajkd.2015.08.029 (2016).","journal-title":"Am. J. Kidney Dis."},{"key":"1844_CR42","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1525-139X.2011.00979.x","volume":"24","author":"TW Meyer","year":"2011","unstructured":"Meyer, T. W., Sirich, T. L. & Hostetter, T. H. Dialysis cannot be dosed. Semin. Dial. 24, 471\u2013479. https:\/\/doi.org\/10.1111\/j.1525-139X.2011.00979.x (2011).","journal-title":"Semin. Dial."},{"key":"1844_CR43","doi-asserted-by":"publisher","first-page":"e0207045","DOI":"10.1371\/journal.pone.0207045","volume":"14","author":"S Steyaert","year":"2019","unstructured":"Steyaert, S., Holvoet, E., Nagler, E., Malfait, S. & Van Biesen, W. Reporting of \u201cdialysis adequacy\u201d as an outcome in randomised trials conducted in adults on haemodialysis. PLoS ONE 14, e0207045. https:\/\/doi.org\/10.1371\/journal.pone.0207045 (2019).","journal-title":"PLoS ONE"},{"key":"1844_CR44","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/S0272-6386(03)00200-2","volume":"41","author":"F Uhlin","year":"2003","unstructured":"Uhlin, F., Fridolin, I., Lindberg, L.-G. & Magnusson, M. Estimation of delivered dialysis dose by on-line monitoring of the ultraviolet absorbance in the spent dialysate. Am. J. Kidney Dis. 41, 1026\u20131036. https:\/\/doi.org\/10.1016\/S0272-6386(03)00200-2 (2003).","journal-title":"Am. J. Kidney Dis."},{"key":"1844_CR45","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/ki.2010.216","volume":"78","author":"A Castellarnau","year":"2010","unstructured":"Castellarnau, A., Werner, M., G\u00fcnthner, R. & Jakob, M. Real-time kt\/v determination by ultraviolet absorbance in spent dialysate: Technique validation. Kidney Int. 78, 920\u2013925. https:\/\/doi.org\/10.1038\/ki.2010.216 (2010).","journal-title":"Kidney Int."},{"key":"1844_CR46","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1177\/0391398818766832","volume":"41","author":"A Mohamed","year":"2018","unstructured":"Mohamed, A. & Davenport, A. Comparison of methods to estimate haemodialysis urea clearance. Int. J. Artif. Organs 41, 371\u2013377. https:\/\/doi.org\/10.1177\/0391398818766832 (2018).","journal-title":"Int. J. Artif. Organs"},{"key":"1844_CR47","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1097\/MAT.0000000000001058","volume":"66","author":"K Lauri","year":"2020","unstructured":"Lauri, K. et al. Removal of urea, \u03b22-microglobulin, and indoxyl sulfate assessed by absorbance and fluorescence in the spent dialysate during hemodialysis. ASAIO J. 66, 698\u2013705. https:\/\/doi.org\/10.1097\/MAT.0000000000001058 (2020).","journal-title":"ASAIO J."},{"key":"1844_CR48","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3390\/toxins13040255","volume":"13","author":"J Paats","year":"2021","unstructured":"Paats, J. et al. Optical method and biochemical source for the assessment of the middle-molecule uremic toxin \u03b22-microglobulin in spent dialysate. Toxins 13, 255. https:\/\/doi.org\/10.3390\/toxins13040255 (2021).","journal-title":"Toxins"},{"key":"1844_CR49","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1159\/000493522","volume":"47","author":"S Kalle","year":"2019","unstructured":"Kalle, S., Tanner, R., Luman, M. & Fridolin, I. Free pentosidine assessment based on fluorescence measurements in spent dialysate. Blood Purif. 47, 85\u201393. https:\/\/doi.org\/10.1159\/000493522 (2019).","journal-title":"Blood Purif."},{"key":"1844_CR50","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.2215\/CJN.02660221","volume":"16","author":"MH Rosner","year":"2021","unstructured":"Rosner, M. H. et al. Classification of uremic toxins and their role in kidney failure. Clin. J. Am. Soc. Nephrol. 16, 1918\u20131928. https:\/\/doi.org\/10.2215\/CJN.02660221 (2021).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1844_CR51","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1177\/0391398820901826","volume":"43","author":"J Meibaum","year":"2020","unstructured":"Meibaum, J., Krause, S., Hillmer, H., Marcelli, D. & Strohh\u00f6fer, C. Identification and characterisation of fluorescent substances in spent dialysis fluid. Int. J. Artif. Organs 43, 579\u2013586. https:\/\/doi.org\/10.1177\/0391398820901826 (2020).","journal-title":"Int. J. Artif. Organs"},{"key":"1844_CR52","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/ckj\/sfac273","volume":"16","author":"J Paats","year":"2023","unstructured":"Paats, J. et al. Time-averaged concentration estimation of uraemic toxins with different removal kinetics: a novel approach based on intradialytic spent dialysate measurements. Clin. Kidney J. 16, 735\u2013744. https:\/\/doi.org\/10.1093\/ckj\/sfac273 (2023).","journal-title":"Clin. Kidney J."},{"key":"1844_CR53","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3390\/toxins4100849","volume":"4","author":"J Arund","year":"2012","unstructured":"Arund, J., Tanner, R., Uhlin, F. & Fridolin, I. Do only small uremic toxins, chromophores, contribute to the online dialysis dose monitoring by uv absorbance?. Toxins 4, 849\u2013861. https:\/\/doi.org\/10.3390\/toxins4100849 (2012).","journal-title":"Toxins"},{"key":"1844_CR54","doi-asserted-by":"publisher","first-page":"b375","DOI":"10.1136\/bmj.b375","volume":"338","author":"KGM Moons","year":"2009","unstructured":"Moons, K. G. M., Royston, P., Vergouwe, Y., Grobbee, D. E. & Altman, D. G. Prognosis and prognostic research: What, why, and how?. BMJ 338, b375\u2013b375. https:\/\/doi.org\/10.1136\/bmj.b375 (2009).","journal-title":"BMJ"},{"key":"1844_CR55","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1053\/j.ackd.2017.09.001","volume":"25","author":"T Shafi","year":"2018","unstructured":"Shafi, T. & Levey, A. S. Measurement and estimation of residual kidney function in patients on dialysis. Adv. Chronic Kidney Dis. 25, 93\u2013104. https:\/\/doi.org\/10.1053\/j.ackd.2017.09.001 (2018).","journal-title":"Adv. Chronic Kidney Dis."},{"key":"1844_CR56","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.xkme.2019.04.002","volume":"1","author":"D Steubl","year":"2019","unstructured":"Steubl, D. et al. Development and validation of residual kidney function estimating equations in dialysis patients. Kidney Med. 1, 104\u2013114. https:\/\/doi.org\/10.1016\/j.xkme.2019.04.002 (2019).","journal-title":"Kidney Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01844-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01844-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01844-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T08:24:22Z","timestamp":1749716662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01844-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1844"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-01844-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,12]]},"assertion":[{"value":"4 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ivo Fridolin is CTO of Optofluid Technologies O\u00dc. Other authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20052"}}